Stockreport

ARS Pharmaceuticals (SPRY) Is Up 5.2% After Securing $250M Term Loan to Accelerate Neffy Launch – Has the Bull Case Changed? [Yahoo! Finance]

ARS Pharmaceuticals, Inc.  (SPRY) 
PDF affiliates of RA Capital Management and OMERS Life Sciences, receiving an initial US$100 million to advance the commercial growth of neffy and support marketing and medi [Read more]